Elevance Health Inc. (ELV) Revenue Growth
Elevance Health Inc. (ELV) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 6.10% |
| 2018-12-31 | 2.29% |
| 2019-12-31 | 13.15% |
| 2020-12-31 | 16.94% |
| 2021-12-31 | 13.76% |
| 2022-12-31 | 12.95% |
| 2023-12-31 | 9.42% |
| 2024-12-31 | 3.31% |
| 2025-12-31 | 12.49% |
How ELV compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ADMA | ADMA Biologics Inc | 19.63% |
| UNH | UnitedHealth Group Incorporated (DE) | 11.81% |
| UTHR | United Therapeutics Corporation | 10.61% |
| HRTX | Heron Therapeutics Inc. | 7.36% |
| ACHC | Acadia Healthcare Company Inc. | 5.04% |
These are five companies in the same sector as ELV with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Elevance Health Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ELV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ELV | $407.50 | -1.76% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 |